Laser Capture Microdissection Market Global Industry Outlook and Demand 2020- Carl Zeiss Ag, Danaher Corporation, Thermo Fisher Scientific, Inc., 3dhistech Ltd, Denova Sciences Pte. Ltd

The global laser capture micro-dissection market is projected to grow at a CAGR of approximately 11.2% during the forecast period (2018-2023). Laser Capture Micro-dissection (LCM) is a contact and contamination-free sample preparation technologyfor isolating specific single cells or entire areas of tissues from a wide variety of samples using direct microscopic visualization. It is an efficient methods for capturing pure cells populations in molecular studies. The report presents an in-depth assessment of the Global Laser Capture Microdissection including enabling technologies, key trends, market drivers, challenges, standardization, regulatory landscape, deployment models, operator case studies, opportunities, future roadmap, value chain, ecosystem player profiles and strategies. The report also presents forecasts for Global Laser Capture Microdissection investments from 2020 till 2025. https://www.marketinsightsreports.com/reports/01241063937/global-laser-capture-microdissection-market-segmented-by-product-instruments-consumables-and-software-and-services-system-type-application-end-user-and-geography-growth-trends-and-forecast-2018-2023/inquiry?Mode=21 Carl Zeiss Ag, Danaher...

Harvard Medical School Dean George Daley voices concerns about new Trump administration restrictions on use of fetal tissue in research

Faulkner aficionados journey from their native Mississippi to a Cambridge bridge to honor a legendary literary character and those lost to suicide Harvard Medical School Dean George Daley discussed the importance of research using fetal tissue, which would otherwise be discarded, in creating vaccines and treatments and enhancing our understanding of human biology. Daley is pictured in 2006 discussing the creation of disease-specific embryonic stem cell lines. Earlier this month, the U.S. Department of Health and Human Services (HHS) announced new restrictions on government-funded research conducted on fetal tissue. The department said it would end such research conducted at the National Institutes of Health and terminate a $2 million contract it had for similar work conducted at the University of California at San Francisco. NIH-funded research done at other institutions, including Harvard, will be allowed to continue until current grants run out. After that, projects seeking funding will be evaluated by a new ethics advisory board before approval. In its statement, HHS also highlighted plans that were announced in December to spend $20 million to search for alternatives to the...